Invivyd’s Covid-directed mAb hits Phase III safety goals
Invivyd’s CEO said the biotech wants to move “as quickly as possible” to bring a new option for Covid protection in the US.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo